(RTTNews) - Spruce Biosciences, Inc. (SPRB), Monday announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to the company's tralesinidase alfa enzyme ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback